학술논문
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Document Type
Article
Author
Murthy, R.K.; Hortobagyi, G.; Loi, S.; Okines, A.; Cameron, D.; Paplomata, E.; Hamilton, E.; Abramson, V.; Hurvitz, S.A.; Slamon, D.; Pegram, M.; Lin, N.U.; Krop, I.; Winer, E.P.; Borges, V.; Anders, C.; Carey, L.A.; Bedard, P.L.; Gelmon, K.; Oliveira, M.; Jakobsen, E.; Bachelot, T.; Shachar, S.S.; Muller, V.; Loibl, S.; Braga, S.; Duhoux, F.P.; Greil, R.; Curigliano, G.; Palanca-Wessels, M.C.; Walker, L.; Feng, W.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 13 February 2020, 382(7):597-609)
Subject
Language
English
ISSN
15334406
00284793
00284793